index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique

Dernières publications

Chiffres clés

54 Publications avec texte intégral

Open Access

76 %

Mots clés

Knockout Cell Biology Becker BMD muscular dystrophy Animal/physiopathology Inbred mdx Cell Line Delivery Long QT Molecular Sequence Data LKB1 Becker muscular dystrophy BMD DMO Energy Metabolism/drug effects Dystrophie musculaire de Becker MES Mdx mouse Male Dystrophie myotonique de type 1 DM1 Becker Muscular Dystrophy Dystrophine Cells Dilated Cardiomyopathy Duchenne muscular dystrophy Mice Duchenne muscular dystrophy DMD Cardiomyopathie Exon skipping Homeostasis CaVβs Drp1 Calcium Allele‐specific silencing therapy Multi resolution modeling Modificateurs de gènes CTNNB1 Dystrophin central domain Ex-vivo LncARN CaVβ1 Inbred C57BL Mitochondrial fission Animals Dystrophie Musculaire de Becker BMD MiARN Base Sequence Molecular docking Gene modifiers Isoformes Dystrophie Musculaire de Duchenne DMD Diseases Gene expression Multiresolution modeling Invivo Liver Centronuclear myopathy Muscle Multi exon skipping Activin Receptors Connexins Gene Expression Regulation/drug effects Human Umbilical Vein Endothelial Cells Isoforms L-Type Humans Epigenetics Calcium Channels Inhibitors Duchenne DMD dystrophy Cell homeostasis CaV subunits Morphogenesis Hear Autophagy Cardiomyopathy Dystrophin-EGFP Antisense oligonucleotides Cachexia Clinical trials Heart Failure Dystrophy Metabolism BMD DHPR α1S Skeletal muscle Immunoglobulin Fc Fragments/pharmacology Génomique Adult muscle stem cells LncRNA Cultured Hepatocellular carcinoma Genomic Jonction neuromusculaire JNM Becker muscular dystrophy CD38 DMD Long noncoding RNA Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Dystrophin Muscle Biology Dynamin 2